mCRPC Treatment Live Exclusives

View Web Version

mCRPC Treatment Live

March 3, 2014

Video summary of the Lancet article "Abiraterone acetate plus prednisone vs. prednisone alone in chemotherapy-naive men with mCRPC," by Charles J. Ryan, MD

Watch Video →

1.5-year post-treatment follow-up of radium-223 dichloride in patients with CRPC and bone metastases from phase 3 ALSYMPCA study, by Sten Nilsson, MD, PhD

Watch Video →

Video review of an advanced prostate cancer patient case, by Paul Sieber, MD

Watch Video →

Treatment of chemotherapy-naive metastatic castration-resistant prostate cancer, by Bryan Mehlhaff, MD

Watch Video →

The effect of low dose GTx-758 on free T levels in mCRPC, by Evan Y. Yu, MD

Watch Video →

mCRPC Treatment

Association of alkaline phosphatase with clinical outcomes in chemotherapy-naïve patients with mCRPC: Results from COU-AA-302

View Poster →

Response to androgen signaling-directed therapy after treatment with abiraterone acetate in patients with mCRPC: Post hoc analysis of study COU-AA-302

View Poster →

Does Gleason score predict efficacy of abiraterone acetate (AA) therapy in patients with mCRPC?

View Poster →


2217 Fifth Street, Berkeley, CA 94710 USA Update Your Email Preferences \| Unsubscribe \| Forward this Email to a Friend

You are receiving this email because you have chosen to receive emails from UroToday.com. Log in to update your email address or view your email preferences. If you have any questions about your account, please log in to contact us securely and we will be happy to assist you.

mCRPC Treatment Live Exclusives

Login